N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE IN HEPATITIS C VIRUS MAINTENANCE HEMODIALYSIS PATIENTS AND ITS RELATION TO DIASTOLIC DYSFUNCTION AND CHILD PUGH SCORE
Zaki, S., Elghoneimy, H., Elwany, M., Labib, A. (2022). N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE IN HEPATITIS C VIRUS MAINTENANCE HEMODIALYSIS PATIENTS AND ITS RELATION TO DIASTOLIC DYSFUNCTION AND CHILD PUGH SCORE. EKB Journal Management System, 4(4), 36-37. doi: 10.21608/alexpo.2022.174867.1511
Sherif Aziz Zaki; Hesham Abdallah Elghoneimy; Mostafa Elwany; Amr Wahid Labib. "N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE IN HEPATITIS C VIRUS MAINTENANCE HEMODIALYSIS PATIENTS AND ITS RELATION TO DIASTOLIC DYSFUNCTION AND CHILD PUGH SCORE". EKB Journal Management System, 4, 4, 2022, 36-37. doi: 10.21608/alexpo.2022.174867.1511
Zaki, S., Elghoneimy, H., Elwany, M., Labib, A. (2022). 'N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE IN HEPATITIS C VIRUS MAINTENANCE HEMODIALYSIS PATIENTS AND ITS RELATION TO DIASTOLIC DYSFUNCTION AND CHILD PUGH SCORE', EKB Journal Management System, 4(4), pp. 36-37. doi: 10.21608/alexpo.2022.174867.1511
Zaki, S., Elghoneimy, H., Elwany, M., Labib, A. N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE IN HEPATITIS C VIRUS MAINTENANCE HEMODIALYSIS PATIENTS AND ITS RELATION TO DIASTOLIC DYSFUNCTION AND CHILD PUGH SCORE. EKB Journal Management System, 2022; 4(4): 36-37. doi: 10.21608/alexpo.2022.174867.1511

N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE IN HEPATITIS C VIRUS MAINTENANCE HEMODIALYSIS PATIENTS AND ITS RELATION TO DIASTOLIC DYSFUNCTION AND CHILD PUGH SCORE

ALEXMED ePosters
Article 4, Volume 4, Issue 4, December 2022, Pages 36-37
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2022.174867.1511
Authors
Sherif Aziz Zaki1; Hesham Abdallah Elghoneimy2; Mostafa Elwany3; Amr Wahid Labib* 2
1Department of Internal Medicine, Faculty of Medicine, Alexandria University
2Nephrology unit, department of internal medicine, Alexandria faculty of medicine, Egypt.
3Department of Cardiology and Angiology, Faculty of Medicine, Alexandria University
Abstract
Introduction:
The prevalence and incidence of end stage renal disease worldwide is rising markedly, becoming a global challenge.
HCV infection is a worldwide public health problem and is more prevalent in hemodialysis patients than the general population.
Cardiovascular complications are the leading cause for excess morbidity and mortality among end stage renal disease patients. Diastolic dysfunction is common in these patients due to left ventricular hypertrophy, myocardial fibrosis.
NT-ProBNP belongs to natriuretic peptides which are molecules secreted by ventricles in response to volume or pressure overload causing natriuresis, vasodilation and diuresis.
NT-ProBNP was found to be elevated in heart failure, renal failure especially patients on hemodialysis (HD).
Many studies showed that HCV patients have increased serum NT ProBNP compared to general population and this level is higher in Child-Pugh C patients compared to Child-Pugh B and A patients and that diastolic dysfunction is more common in those patients.
Aim of the work:
The aim of this work was to study the level of NT-ProBNP in HCV patients on maintenance hemodialysis (MHD) and its correlation with diastolic dysfunction and Child-Pugh classification.
Keywords
NTprobnp; DIASTOLIC DYSFUNCTION; HCV
Supplementary Files
Statistics
Article View: 97